Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Comparative Effectiveness Research On Track To Be Resolved In Conference

This article was originally published in The Pink Sheet Daily

Executive Summary

Independent versus government-based CER group is one of issues likely to be left to House/Senate negotiators.

You may also be interested in...



CER And Personalized Medicine Are "Synergistic" - FDA's Woodcock

The goals of comparative effectiveness research and personalized medicine might appear at odds or at least as leading to divergent paths, with one focusing on the best treatment for a population and the other on the best treatment for an individual

CER And Personalized Medicine Are "Synergistic" - FDA's Woodcock

The goals of comparative effectiveness research and personalized medicine might appear at odds or at least as leading to divergent paths, with one focusing on the best treatment for a population and the other on the best treatment for an individual

Merged House Health Bill Seeks More Part D Drug Savings, Sets Broad Medicaid Expansion

Many of the bill's provisions specifically related to the biopharmaceutical industry are relatively unchanged from earlier versions that emerged from three House committees.

Related Content

Topics

UsernamePublicRestriction

Register

PS068676

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel